Clinical Trial Update: OH2 Injection in Melanoma [Phase 3]

View source ↗

Summary

OH2 Injection is in Phase 3 clinical trials for melanoma. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• OH2 Injection

Snippet

Sponsor: Binhui Biopharmaceutical Co., Ltd. | Conditions: Melanoma | Phase 3 | Status: RECRUITING